Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627484 · ClinicalTrials.gov registry record
Changes in Insulin Sensitivity After Weight Loss
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 119
- Enrollment target
NCT00627484: Completed study, sponsored by Columbia University.
NCT00627484 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00627484 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
This study is designed to compare the changes in insulin sensitivity as well as gastrointestinal hormone levels in diabetic and non-diabetic obese individuals who are undergoing weight loss procedures. The main hypothesis of this study is that weight loss induced by gastric bypass will induce a greater improvement in insulin sensitivity compared with gastric banding or low calorie diet. Subjects will be studied before and after weight loss. Studies consist of intravenous glucose tolerance test, body composition analysis, meal test, and energy expenditure.
Primary Outcome
Measured by frequently sampled intravenous glucose tolerance test (FSIVGTT)
Interventions
- PROCEDURE Gastric bypass
- PROCEDURE Sleeve gastrectomy
- PROCEDURE Gastric banding
- BEHAVIORAL Very low calorie diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2005-03-01 |
| Est. Completion | 2018-06-17 |
What the finished NCT00627484 record still lists
NCT00627484 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Gastric bypass is the first listed.
NCT00627484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00627484 about?
NCT00627484 is a clinical study titled "Changes in Insulin Sensitivity After Weight Loss". This study is designed to compare the changes in insulin sensitivity as well as gastrointestinal hormone levels in diabetic and non-diabetic obese individuals who are undergoing weight loss procedures. The main hypothesis of this study is that weight loss induced by gastric bypass will induce a grea...
What is the current status of trial NCT00627484?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2005-03-01. Estimated completion is 2018-06-17.
What interventions are being tested in trial NCT00627484?
The interventions under investigation include: Gastric bypass (PROCEDURE), Sleeve gastrectomy (PROCEDURE), Gastric banding (PROCEDURE), Very low calorie diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00627484?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI